Radiopharm Theranostics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 51.00 M | $670.50 K | 0.00% | 129,474.49% |
| HSBC HOLDINGS PLC | 08/14/2026 | 62.19 K | $253.73 K | 1.33% | 157.88% |
| REGAL PARTNERS LTD | 08/14/2026 | 40.14 K | $168.18 K | 0.00% | 101.90% |
| PNC FINANCIAL SERVICES GROUP, INC. | 08/07/2026 | 20.00 K | $83.80 K | 25.00% | 50.77% |
| UBS GROUP AG | 08/13/2026 | 1.51 K | $6.31 K | -49.77% | 3.83% |
| INTEGRATED WEALTH CONCEPTS LLC | 08/12/2026 | 1.31 K | $5.49 K | 100.00% | 3.33% |
| RHUMBLINE ADVISERS | 08/12/2026 | 195 | $817 | 61.16% | 0.50% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Radiopharm Theranostics Ltd institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Radiopharm Theranostics Ltd. The most heavily invested institutionals were:
Stonepine Capital Management, LLC: 51 M
HSBC HOLDINGS PLC: 62,188
Regal Partners Ltd: 40,138
PNC FINANCIAL SERVICES GROUP, INC.: 20,000
UBS Group AG: 1,507
Integrated Wealth Concepts LLC: 1,310
129,792.68% of Radiopharm Theranostics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 51.13 M shares in the last 24 months. This purchase volume represents approximately $252.56 M in transactions.